SCHEMBL16986343

SCHEMBL16986343

COc1ccc(Nc2nc3[nH]c(=O)c(-c4ccc(F)cc4)cc3c(=O)[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.55
▸ PDE9A O76083 5/20 0.48
▸ MAPT P10636 6/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ GSK3B P49841 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ACP1 P24666 1/20 0.45
▸ CDC25B P30305 1/20 0.45
▸ GAA P10253 1/20 0.44
▸ USP2 O75604 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ PTPN7 P35236 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ WRN Q14191 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16986337 0.86 MAPT (0.48) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL16986307 0.77 MAPT (0.49) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL28278329 0.71 KDM4E (1.00) KDM4EPDE9AMAPTKMT2AMEN1
SCHEMBL19660767 0.69 MAPT (0.68) KDM4EMAPTKMT2AMEN1GSK3B
SCHEMBL16986369 0.67 KDM4E (0.44) KDM4EPDE9AMAPTHTTLMNA
SCHEMBL866356 0.67 MAPT (0.77) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL28103470 0.67 KDM4E (0.69) KDM4EMAPTKMT2AMEN1LMNA
SCHEMBL22719039 0.66 MAOB (0.43) KDM4EKMT2AMEN1GSK3BCDC25B
SCHEMBL13011769 0.65 TNKS (0.64) KDM4EMAPTALDH1A1
SCHEMBL16981666 0.65 PDE9A (1.00) PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015118110-A1 PYRIDO[2,3-D]PYRIMIDINE-7(8H)-ONE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C INSTITUT QUÍMIC DE SARRIÁ, CETS FUNDACIÓ PRIVADA (ES) 2015-08-13 — — WO claimed
EP-2905024-A1 Pyrido[2,3-d]pyrimidine-7(8H)-one derivatives for the treatment of infections caused by Flaviviridae Institut Quimic De Sarriá Cets, Fundació Privada (ES) 2015-08-12 — — EP claimed
WO-2015118110-A1 PYRIDO[2,3-D]PYRIMIDINE-7(8H)-ONE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C INSTITUT QUÍMIC DE SARRIÁ, CETS FUNDACIÓ PRIVADA (ES) 2015-08-13 — — WO disclosed
WO-2015118110-A1 PYRIDO[2,3-D]PYRIMIDINE-7(8H)-ONE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C INSTITUT QUÍMIC DE SARRIÁ, CETS FUNDACIÓ PRIVADA (ES) 2015-08-13 — — WO disclosed
EP-2905024-A1 Pyrido[2,3-d]pyrimidine-7(8H)-one derivatives for the treatment of infections caused by Flaviviridae Institut Quimic De Sarriá Cets, Fundació Privada (ES) 2015-08-12 — — EP disclosed
EP-2905024-A1 Pyrido[2,3-d]pyrimidine-7(8H)-one derivatives for the treatment of infections caused by Flaviviridae Institut Quimic De Sarriá Cets, Fundació Privada (ES) 2015-08-12 — — EP disclosed
Send feedback